This afternoon, Hunter Maritime (HUNT) released the results of their shareholder vote to extend the date by which the company must consummate its initial business combination from November 23, 2018 to April 23, 2019. The amendment was approved, however, no further details were given.
Additionally, there are two parts to this “extension” and the Extension Tender Offer part of it is still not complete. The Tender Offer, which began on October 5, 2018, will still be open until 5:00PM (ET) November 6, 2018.
By way of further explanation, the Extension Amendment will not be approved unless the Extension Tender Offer is consummated. Furthermore, the Extension Tender Offer would not be consummated unless the Extension Amendment was approved. It’s all very confusing, but what you need to know is, Hunter made it past the first hurdle (the Extension Amendment approval by vote) and now they just need to wrap up the Tender Offer.
You can read the press release here, but so far it’s looking good for Hunter Maritime. Red skies at night….
AGBA (NASDAQ:AGBA) stock is up over +90% this morning following a +211% premarket spike on news it has signed a definitive agreement to combine with social streaming video platform Triller. AGBA, the company itself, was formed by the $555 million combination between a SPAC of the same name and TAG Companies, a financial services firm...
At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...
Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...
At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...
Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...